Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cells.

Mitton B, Chae HD, Hsu K, Dutta R, Aldana-Masangkay G, Ferrari R, Davis K, Tiu BC, Kaul A, Lacayo N, Dahl G, Xie F, Li BX, Breese MR, Landaw EM, Nolan G, Pellegrini M, Romanov S, Xiao X, Sakamoto KM.

Leukemia. 2016 Dec;30(12):2302-2311. doi: 10.1038/leu.2016.139. Epub 2016 May 23.

2.

Increased abscess formation and defective chemokine regulation in CREB transgenic mice.

Wen AY, Landaw EM, Ochoa R, Cho M, Chao A, Lawson G, Sakamoto KM.

PLoS One. 2013;8(2):e55866. doi: 10.1371/journal.pone.0055866. Epub 2013 Feb 6.

3.

Enhanced growth inhibition of osteosarcoma by cytotoxic polymerized liposomal nanoparticles targeting the alcam cell surface receptor.

Federman N, Chan J, Nagy JO, Landaw EM, McCabe K, Wu AM, Triche T, Kang H, Liu B, Marks JD, Denny CT.

Sarcoma. 2012;2012:126906. Epub 2012 Sep 11.

4.

Sox4 cooperates with CREB in myeloid transformation.

Sandoval S, Kraus C, Cho EC, Cho M, Bies J, Manara E, Accordi B, Landaw EM, Wolff L, Pigazzi M, Sakamoto KM.

Blood. 2012 Jul 5;120(1):155-65. doi: 10.1182/blood-2011-05-357418. Epub 2012 May 24.

5.

Target-specific capture enhances sensitivity of electrochemical detection of bacterial pathogens.

Patel M, Gonzalez R, Halford C, Lewinski MA, Landaw EM, Churchill BM, Haake DA.

J Clin Microbiol. 2011 Dec;49(12):4293-6. doi: 10.1128/JCM.01261-11. Epub 2011 Sep 21.

6.

Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells.

Aldana-Masangkay GI, Rodriguez-Gonzalez A, Lin T, Ikeda AK, Hsieh YT, Kim YM, Lomenick B, Okemoto K, Landaw EM, Wang D, Mazitschek R, Bradner JE, Sakamoto KM.

Leuk Lymphoma. 2011 Aug;52(8):1544-55. doi: 10.3109/10428194.2011.570821. Epub 2011 Jun 23.

7.

The multitargeted receptor tyrosine kinase inhibitor linifanib (ABT-869) induces apoptosis through an Akt and glycogen synthase kinase 3β-dependent pathway.

Hernandez-Davies JE, Zape JP, Landaw EM, Tan X, Presnell A, Griffith D, Heinrich MC, Glaser KB, Sakamoto KM.

Mol Cancer Ther. 2011 Jun;10(6):949-59. doi: 10.1158/1535-7163.MCT-10-0904. Epub 2011 Apr 6.

8.

ABT-869 inhibits the proliferation of Ewing Sarcoma cells and suppresses platelet-derived growth factor receptor beta and c-KIT signaling pathways.

Ikeda AK, Judelson DR, Federman N, Glaser KB, Landaw EM, Denny CT, Sakamoto KM.

Mol Cancer Ther. 2010 Mar;9(3):653-60. doi: 10.1158/1535-7163.MCT-09-0812. Epub 2010 Mar 2.

9.

Optimal probe length and target location for electrochemical detection of selected uropathogens at ambient temperature.

Mastali M, Babbitt JT, Li Y, Landaw EM, Gau V, Churchill BM, Haake DA.

J Clin Microbiol. 2008 Aug;46(8):2707-16. doi: 10.1128/JCM.00423-08. Epub 2008 Jun 18.

10.

Rapid antimicrobial susceptibility determination of uropathogens in clinical urine specimens by use of ATP bioluminescence.

Ivancic V, Mastali M, Percy N, Gornbein J, Babbitt JT, Li Y, Landaw EM, Bruckner DA, Churchill BM, Haake DA.

J Clin Microbiol. 2008 Apr;46(4):1213-9. doi: 10.1128/JCM.02036-07. Epub 2008 Feb 13.

11.

CREB is a critical regulator of normal hematopoiesis and leukemogenesis.

Cheng JC, Kinjo K, Judelson DR, Chang J, Wu WS, Schmid I, Shankar DB, Kasahara N, Stripecke R, Bhatia R, Landaw EM, Sakamoto KM.

Blood. 2008 Feb 1;111(3):1182-92. Epub 2007 Nov 1.

12.

Development of an advanced electrochemical DNA biosensor for bacterial pathogen detection.

Liao JC, Mastali M, Li Y, Gau V, Suchard MA, Babbitt J, Gornbein J, Landaw EM, McCabe ER, Churchill BM, Haake DA.

J Mol Diagn. 2007 Apr;9(2):158-68.

13.

Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutants.

Skaggs BJ, Gorre ME, Ryvkin A, Burgess MR, Xie Y, Han Y, Komisopoulou E, Brown LM, Loo JA, Landaw EM, Sawyers CL, Graeber TG.

Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19466-71. Epub 2006 Dec 12.

14.

Quantitative analysis of the dysnatremias.

Nguyen MK, Landaw EM, Kurtz I.

Kidney Int. 2006 Oct;70(7):1379-81; author reply 1381-2. No abstract available.

15.

Use of electrochemical DNA biosensors for rapid molecular identification of uropathogens in clinical urine specimens.

Liao JC, Mastali M, Gau V, Suchard MA, Møller AK, Bruckner DA, Babbitt JT, Li Y, Gornbein J, Landaw EM, McCabe ER, Churchill BM, Haake DA.

J Clin Microbiol. 2006 Feb;44(2):561-70.

16.

Initial high-dose nasal allergen exposure prevents allergic sensitization to a neoantigen.

Riedl MA, Landaw EM, Saxon A, Diaz-Sanchez D.

J Immunol. 2005 Jun 1;174(11):7440-5.

17.

The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia.

Shankar DB, Cheng JC, Kinjo K, Federman N, Moore TB, Gill A, Rao NP, Landaw EM, Sakamoto KM.

Cancer Cell. 2005 Apr;7(4):351-62.

18.

Renal clear-cell carcinoma: an ultrastructural study on the junctional complexes.

Kim G, Rajasekaran SA, Thomas G, Rosen EA, Landaw EM, Shintaku P, Lassman C, Said J, Rajasekaran AK.

Histol Histopathol. 2005 Jan;20(1):35-44. doi: 10.14670/HH-20.35.

PMID:
15578420
19.

Comparison of bone marrow aspirates and biopsies in pediatric patients with ALL at days 7 and 14 of induction therapy.

Countouriotis A, Landaw EM, Naeim F, Moore TB, Sakamoto KM.

Leuk Lymphoma. 2004 Apr;45(4):745-7.

PMID:
15160950
20.

Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia.

Crans-Vargas HN, Landaw EM, Bhatia S, Sandusky G, Moore TB, Sakamoto KM.

Blood. 2002 Apr 1;99(7):2617-9.

PMID:
11895805
21.

Toxicokinetic interaction of 2,5-hexanedione and methyl ethyl ketone.

Yu RC, Hattis D, Landaw EM, Froines JR.

Arch Toxicol. 2002 Jan;75(11-12):643-52.

PMID:
11876497
22.

Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity.

Petz LD, Garratty G, Calhoun L, Clark BD, Terasaki PI, Gresens C, Gornbein JA, Landaw EM, Smith R, Cecka JM.

Transfusion. 2000 Dec;40(12):1446-56.

PMID:
11134563
23.

Acute upregulation of blood-brain barrier glucose transporter activity in seizures.

Cornford EM, Nguyen EV, Landaw EM.

Am J Physiol Heart Circ Physiol. 2000 Sep;279(3):H1346-54.

24.

Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor.

Coloma MJ, Lee HJ, Kurihara A, Landaw EM, Boado RJ, Morrison SL, Pardridge WM.

Pharm Res. 2000 Mar;17(3):266-74.

PMID:
10801214
25.

A model-based approach for assessing in vivo combination therapy interactions.

Lopez AM, Pegram MD, Slamon DJ, Landaw EM.

Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13023-8.

26.

Testing the fit of a quantal model of neurotransmission.

Greenwood AC, Landaw EM, Brown TH.

Biophys J. 1999 Apr;76(4):1847-55.

27.

An analysis of a class of DNA sequence reading molecules.

Walker WL, Goodsell DS, Landaw EM.

J Comput Biol. 1998 Fall;5(3):571-83.

PMID:
9773351
29.

Dynamic [18F]fluorodeoxyglucose positron emission tomography and hypometabolic zones in seizures: reduced capillary influx.

Cornford EM, Gee MN, Swartz BE, Mandelkern MA, Blahd WH, Landaw EM, Delgado-Escueta AV.

Ann Neurol. 1998 Jun;43(6):801-8.

PMID:
9629850
30.

The theoretical limits of DNA sequence discrimination by linked polyamides.

Walker WL, Landaw EM, Dickerson RE, Goodsell DS.

Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4315-20.

31.

Interictal seizure resections show two configurations of endothelial Glut1 glucose transporter in the human blood-brain barrier.

Cornford EM, Hyman S, Cornford ME, Landaw EM, Delgado-Escueta AV.

J Cereb Blood Flow Metab. 1998 Jan;18(1):26-42.

PMID:
9428303
32.

Estimation of the DNA sequence discriminatory ability of hairpin-linked lexitropsins.

Walker WL, Landaw EM, Dickerson RE, Goodsell DS.

Proc Natl Acad Sci U S A. 1997 May 27;94(11):5634-9.

33.

Safety of filtered leukocyte-reduced blood products for prevention of transfusion-associated cytomegalovirus infection.

Landaw EM, Kanter M, Petz LD.

Blood. 1996 Jun 1;87(11):4910. No abstract available.

PMID:
8639866
34.

Suramin in hormone-refractory metastatic prostate cancer: a drug with limited efficacy.

Rosen PJ, Mendoza EF, Landaw EM, Mondino B, Graves MC, McBride JH, Turcillo P, deKernion J, Belldegrun A.

J Clin Oncol. 1996 May;14(5):1626-36.

PMID:
8622081
35.

Developmental modulation of blood-brain-barrier glucose transport in the rabbit.

Cornford EM, Hyman S, Landaw EM.

Brain Res. 1994 Nov 7;663(1):7-18.

PMID:
7850472
36.

Unrelated donor bone marrow transplants in children.

Grovas A, Feig SA, O'Rourke S, Valentino L, Wiley F, Hunt L, Landaw EM, Gajewski J.

Cell Transplant. 1994 Sep-Oct;3(5):413-20.

PMID:
7827779
37.

Exchange of CO2 and bicarbonate between the circulation and cerebrospinal fluid in piglets.

Chambliss CR, Mohan O, Moromisato M, Garner DJ, Landaw EM, Cooper DM.

Am J Respir Crit Care Med. 1994 Aug;150(2):503-9.

PMID:
8049837
38.

N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome.

Paquette RL, Landaw EM, Pierre RV, Kahan J, Lübbert M, Lazcano O, Isaac G, McCormick F, Koeffler HP.

Blood. 1993 Jul 15;82(2):590-9.

PMID:
8329714
39.

In vitro insulin-like growth factor-I, growth hormone, and insulin resistance occurs in symptomatic human immunodeficiency virus-1-infected children.

Geffner ME, Yeh DY, Landaw EM, Scott ML, Stiehm ER, Bryson YJ, Israele V.

Pediatr Res. 1993 Jul;34(1):66-72.

PMID:
8356022
40.

Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery.

Bickel U, Yoshikawa T, Landaw EM, Faull KF, Pardridge WM.

Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2618-22.

41.

A behavioral and pharmacokinetic study of the actions of phenylcyclohexyldiethylamine and its active metabolite, phenylcyclohexylethylamine.

Cho AK, Hiramatsu M, Schmitz DA, Vargas HM, Landaw EM.

J Pharmacol Exp Ther. 1993 Mar;264(3):1401-5.

PMID:
8450474
42.

A pharmacokinetic study of phenylcyclohexyldiethylamine. An analog of phencyclidine.

Cho AK, Hiramatsu M, Schmitz DA, Landaw EM, Chang AS, Ramamurthy S, Jenden DJ.

Drug Metab Dispos. 1993 Jan-Feb;21(1):125-32.

PMID:
8095205
43.

Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate.

Gajewski JL, Petz LD, Calhoun L, O'Rourke S, Landaw EM, Lyddane NR, Hunt LA, Schiller GJ, Ho WG, Champlin RE.

Blood. 1992 Jun 1;79(11):3076-85.

PMID:
1586749
44.

DIMSUM: an expert system for multiexponential model discrimination.

Marino AT, Distefano JJ 3rd, Landaw EM.

Am J Physiol. 1992 Apr;262(4 Pt 1):E546-56.

PMID:
1566840
45.

Increase in bicarbonate stores with exercise.

Barstow TJ, Landaw EM, Springer C, Cooper DM.

Respir Physiol. 1992 Feb;87(2):231-42.

46.

13CO2 washout kinetics in acute hypercapnia.

Mohan OE, Cooper DM, Jensen SC, Armon Y, Landaw EM.

Respir Physiol. 1991 Nov;86(2):159-70.

47.

Influence of increased metabolic rate on [13C]bicarbonate washout kinetics.

Barstow TJ, Cooper DM, Sobel EM, Landaw EM, Epstein S.

Am J Physiol. 1990 Jul;259(1 Pt 2):R163-71.

48.

Childhood hypoglycemia: differentiating hyperinsulinemic from nonhyperinsulinemic causes.

Antunes JD, Geffner ME, Lippe BM, Landaw EM.

J Pediatr. 1990 Jan;116(1):105-8. No abstract available.

PMID:
2404096
49.

Tegumental glucose permeability in male and female Schistosoma mansoni.

Cornford EM, Fitzpatrick AM, Quirk TL, Diep CP, Landaw EM.

J Parasitol. 1988 Feb;74(1):116-28.

PMID:
3357096
50.

A minimax approach to the single-point method of drug dosing.

Bahn MM, Landaw EM.

J Pharmacokinet Biopharm. 1987 Jun;15(3):255-69.

PMID:
3668803

Supplemental Content

Loading ...
Support Center